Institution
Erasmus MC Cancer Institute
Also known as: Erasmus MC Daniel den Hoed · Erasmus MC Kanker Instituut
- 4running trials
- 5closed trials
- 2researchers
- 11,828publications (OpenAlex)
Researchers
Running trials
Recruiting
Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients
Recruiting
Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC
Active, not recruiting
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection
Completed
Terminated
Terminated
Completed
Registry name variants (3)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Erasmus MC Cancer Institute
Rotterdam, 3015GD
8 trials
Erasmus MC Cancer Institute - location Daniel den Hoed
Rotterdam
1 trial
NCT01942603Minimal SN Tumor Burden
Erasmus MC Cancer Institute
Groningen
Conditions
Diseases this institution publishes on or runs trials for.
- Prostate cancer62 works · 1 trial
- Melanoma37 works · 1 trial
- Bladder cancer31 works · 0 trials
- Acute myeloid leukaemia29 works · 0 trials
- Pancreatic cancer28 works · 1 trial
- Neuroendocrine tumours25 works · 0 trials
- Multiple myeloma24 works · 0 trials
- Head and neck cancer19 works · 1 trial
- Myeloproliferative neoplasms7 works · 0 trials
- Mantle cell lymphoma4 works · 0 trials
- Barrett's oesophagus3 works · 0 trials
Institution data: ROR 03r4m3349 (CC0-1.0)Updated 12 Nov 2026